NEUCA S.A. (WSE:NEU)
750.00
0.00 (0.00%)
May 27, 2026, 12:55 PM CET
NEUCA Revenue
NEUCA had revenue of 3.56B PLN in the quarter ending March 31, 2026, with 5.68% growth. This brings the company's revenue in the last twelve months to 13.83B, up 7.95% year-over-year. In the year 2025, NEUCA had annual revenue of 13.64B with 8.18% growth.
Revenue (ttm)
13.83B
Revenue Growth
+7.95%
P/S Ratio
0.24
Revenue / Employee
2.67M
Employees
5,339
Market Cap
3.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.64B | 1.03B | 8.18% |
| Dec 31, 2024 | 12.61B | 799.12M | 6.76% |
| Dec 31, 2023 | 11.81B | 580.45M | 5.17% |
| Dec 31, 2022 | 11.23B | 1.37B | 13.87% |
| Dec 31, 2021 | 9.86B | 619.37M | 6.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.42B |
| Centrum Medyczne ENEL-MED | 854.27M |
| Synektik Spólka Akcyjna | 706.45M |
| Mercator Medical | 585.57M |
| Voxel | 583.79M |
| Selvita | 359.93M |
| Celon Pharma | 226.35M |
| Ryvu Therapeutics | 88.38M |
NEUCA News
- 6 days ago - NEUCA Quarterly report: Q1 2026 - Filings
- 6 days ago - NEUCA Slides: Q1 2026 - Filings
- 2 months ago - NEUCA Slides: H2 2025 - Filings
- 2 months ago - NEUCA Annual report: H2 2025 - Filings
- 6 months ago - NEUCA Quarterly report: Q3 2025 - Filings
- 6 months ago - NEUCA Slides: Q3 2025 - Filings
- 9 months ago - NEUCA Quarterly report: H1 2025 - Filings
- 9 months ago - NEUCA Slides: H1 2025 - Filings